Cytochrome P450 2D6 Phenotyping in an Elderly Population With Dementia and Response to Galantamine in Dementia: A Pilot Study
Sunday, July 31st, 2011Publication year: 2011
Source: The American Journal of Geriatric Pharmacotherapy, In Press, Corrected Proof, Available online 30 July 2011
Jo-Anne, Clarke , Murray, Cutler , Inna, Gong , Ute I., Schwarz , David, Freeman , …
Background: The cytochrome P450 (CYP) 2D6 enzyme is involved in the metabolism of many drugs used by the elderly population. Variations in its activity can lead to altered drug response. However, few studies on the activity of this enzyme system have enrolled the elderly population. Objective: The goal of this pilot study was to assess the feasibility of in vivo phenotyping of CYP2D6 in an elderly population with dementia and to determine if part of the variability in response to treatment with galantamine is attributable to CYP2D6 phenotype. Methods: Patients with dementia attending geriatric clinics and receiving galantamine treatment for at least 6 months were…